Xing Wang Song

Learn More
BACKGROUND Serum apolipoprotein (apo) A-I was considered to be an immune regulator and could suppress pro-inflammatory cytokines generated by activated T cell in some autoimmune diseases. However, the change of serum apoA-I levels in multiple sclerosis (MS) patients is unknown. METHODS In the presentation we performed a study on serum apoA-I levels in the(More)
  • 1